세계의 말 헬스케어 시장 조사 보고서 : 산업 분석, 규모, 점유율, 성장, 동향, 예측(2024-2032년)

The global demand for Equine Healthcare Market is presumed to reach the market size of nearly USD 6.18 Billion by 2032 from USD 3.46 Billion in 2023 with a CAGR of 6.68% under the study period 2024-2032.

Equine healthcare encompasses veterinary care and management practices aimed at maintaining horses' health and well-being. It includes preventive measures such as vaccinations, deworming, dental care, nutritional management, and diagnostic and treatments for various conditions that affect horses. Its providers, including veterinarians and equine specialists, play an pivotal role in ensuring the longevity and performance of horses in multiple sectors, including equestrian sports, racing, recreation, and breeding.

MARKET DYNAMICS

The increasing adoption of horses for recreational activities, sports, and therapeutic purposes globally drives demand for comprehensive healthcare solutions. This trend is especially notable in developed regions where horse ownership is a significant part of cultural and leisure activities. Advancements in veterinary medicine and technology have led to the development of specialized treatments and diagnostic tools for equine health conditions. Innovations such as regenerative therapies, advanced imaging techniques (like MRI and CT scans), and minimally invasive surgical procedures improve diagnostic accuracy and treatment outcomes, thereby expanding equine healthcare market opportunities. Moreover, rising awareness among horse owners and trainers about the importance of preventive healthcare measures, nutrition management, and performance enhancement further fuels equine healthcare market growth. Increased spending on premium healthcare products and services for horses underscores the growing demand for high-quality veterinary care and specialized treatments in the equine sector. However, economic constraints may lead to reduced expenditures on non-essential healthcare services and products for horses, limiting the equine healthcare market.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of Equine Healthcare. The growth and trends of Equine Healthcare industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the Equine Healthcare market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Product

• Vaccines
• Pharmaceuticals (Parasiticides, Anti-infectives, Anti-inflammatory & Analgesics, Other Pharmaceuticals)
• Medicinal Feed Additives
• Diagnostics
• Software & Services
• Others

By Indication

• Musculoskeletal Disorders
• Parasite Control
• Internal Medicine
• Equine Herpes Virus
• Equine Encephalomyelitis
• Equine Influenza
• West Nile Virus
• Tetanus
• Others

By Activity

• Sports/Racing
• Recreation
• Others

By Distribution Channel

• Veterinary Hospitals & Clinics
• E-commerce
• Others

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Equine Healthcare market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Equine Healthcare market include Zoetis, Boehringer Ingelheim International GmbH, Ceva, Sound, Merck & Co. Inc., Hallmarq Veterinary Imaging, Esaote SPA, Vetoquinol S.A., Idexx Laboratories Inc., Dechra Pharmaceuticals PLC. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

TABLE OF CONTENTS

1. PREFACE

• 1.1. Report Description
  • 1.1.1 Objective
  • 1.1.2 Target Audience
  • 1.1.3 Unique Selling Proposition (USP) & offerings
• 1.2. Research Scope
• 1.3. Research Methodology
  • 1.3.1 Market Research Process
  • 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

• 2.1. Highlights of Market
• 2.2. Global Market Snapshot

3. EQUINE HEALTHCARE - INDUSTRY ANALYSIS

• 3.1. Introduction - Market Dynamics
• 3.2. Market Drivers
• 3.3. Market Restraints
• 3.4. Opportunities
• 3.5. Industry Trends
• 3.6. Porter's Five Force Analysis
• 3.7. Market Attractiveness Analysis
  • 3.7.1 Market Attractiveness Analysis By Product
  • 3.7.2 Market Attractiveness Analysis By Indication
  • 3.7.3 Market Attractiveness Analysis By Activity
  • 3.7.4 Market Attractiveness Analysis By Distribution Channel
  • 3.7.5 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

• 4.1. Value Chain Analysis
• 4.2. Raw Material Analysis
  • 4.2.1 List of Raw Materials
  • 4.2.2 Raw Material Manufactures List
  • 4.2.3 Price Trend of Key Raw Materials
• 4.3. List of Potential Buyers
• 4.4. Marketing Channel
  • 4.4.1 Direct Marketing
  • 4.4.2 Indirect Marketing
  • 4.4.3 Marketing Channel Development Trend

5. GLOBAL EQUINE HEALTHCARE MARKET ANALYSIS BY PRODUCT

• 5.1. Overview By Product
• 5.2. Historical and Forecast Data Analysis By Product
• 5.3. Vaccines Historic and Forecast Sales By Regions
• 5.4. Pharmaceuticals (Parasiticides, Anti-infectives, Anti-inflammatory & Analgesics, Other Pharmaceuticals) Historic and Forecast Sales By Regions
• 5.5. Medicinal Feed Additives Historic and Forecast Sales By Regions
• 5.6. Diagnostics Historic and Forecast Sales By Regions
• 5.7. Software & Services Historic and Forecast Sales By Regions
• 5.8. Others Historic and Forecast Sales By Regions

6. GLOBAL EQUINE HEALTHCARE MARKET ANALYSIS BY INDICATION

• 6.1. Overview By Indication
• 6.2. Historical and Forecast Data Analysis By Indication
• 6.3. Musculoskeletal Disorders Historic and Forecast Sales By Regions
• 6.4. Parasite Control Historic and Forecast Sales By Regions
• 6.5. Internal Medicine Historic and Forecast Sales By Regions
• 6.6. Equine Herpes Virus Historic and Forecast Sales By Regions
• 6.7. Equine Encephalomyelitis Historic and Forecast Sales By Regions
• 6.8. Equine Influenza Historic and Forecast Sales By Regions
• 6.9. West Nile Virus Historic and Forecast Sales By Regions
• 6.10. Tetanus Historic and Forecast Sales By Regions
• 6.11. Others Historic and Forecast Sales By Regions

7. GLOBAL EQUINE HEALTHCARE MARKET ANALYSIS BY ACTIVITY

• 7.1. Overview By Activity
• 7.2. Historical and Forecast Data Analysis By Activity
• 7.3. Sports/Racing Historic and Forecast Sales By Regions
• 7.4. Recreation Historic and Forecast Sales By Regions
• 7.5. Others Historic and Forecast Sales By Regions

8. GLOBAL EQUINE HEALTHCARE MARKET ANALYSIS BY DISTRIBUTION CHANNEL

• 8.1. Overview By Distribution Channel
• 8.2. Historical and Forecast Data Analysis By Distribution Channel
• 8.3. Veterinary Hospitals & Clinics Historic and Forecast Sales By Regions
• 8.4. E-commerce Historic and Forecast Sales By Regions
• 8.5. Others Historic and Forecast Sales By Regions

9. GLOBAL EQUINE HEALTHCARE MARKET ANALYSIS BY GEOGRAPHY

• 9.1. Regional Outlook
• 9.2. Introduction
• 9.3. North America Sales Analysis
  • 9.3.1 Overview, Historic and Forecast Data Sales Analysis
  • 9.3.2 North America By Segment Sales Analysis
  • 9.3.3 North America By Country Sales Analysis
  • 9.3.4 United States Sales Analysis
  • 9.3.5 Canada Sales Analysis
  • 9.3.6 Mexico Sales Analysis
• 9.4. Europe Sales Analysis
  • 9.4.1 Overview, Historic and Forecast Data Sales Analysis
  • 9.4.2 Europe By Segment Sales Analysis
  • 9.4.3 Europe By Country Sales Analysis
  • 9.4.4 United Kingdom Sales Analysis
  • 9.4.5 France Sales Analysis
  • 9.4.6 Germany Sales Analysis
  • 9.4.7 Italy Sales Analysis
  • 9.4.8 Russia Sales Analysis
  • 9.4.9 Rest Of Europe Sales Analysis
• 9.5. Asia Pacific Sales Analysis
  • 9.5.1 Overview, Historic and Forecast Data Sales Analysis
  • 9.5.2 Asia Pacific By Segment Sales Analysis
  • 9.5.3 Asia Pacific By Country Sales Analysis
  • 9.5.4 China Sales Analysis
  • 9.5.5 India Sales Analysis
  • 9.5.6 Japan Sales Analysis
  • 9.5.7 South Korea Sales Analysis
  • 9.5.8 Australia Sales Analysis
  • 9.5.9 South East Asia Sales Analysis
  • 9.5.10 Rest Of Asia Pacific Sales Analysis
• 9.6. Latin America Sales Analysis
  • 9.6.1 Overview, Historic and Forecast Data Sales Analysis
  • 9.6.2 Latin America By Segment Sales Analysis
  • 9.6.3 Latin America By Country Sales Analysis
  • 9.6.4 Brazil Sales Analysis
  • 9.6.5 Argentina Sales Analysis
  • 9.6.6 Peru Sales Analysis
  • 9.6.7 Chile Sales Analysis
  • 9.6.8 Rest of Latin America Sales Analysis
• 9.7. Middle East & Africa Sales Analysis
  • 9.7.1 Overview, Historic and Forecast Data Sales Analysis
  • 9.7.2 Middle East & Africa By Segment Sales Analysis
  • 9.7.3 Middle East & Africa By Country Sales Analysis
  • 9.7.4 Saudi Arabia Sales Analysis
  • 9.7.5 UAE Sales Analysis
  • 9.7.6 Israel Sales Analysis
  • 9.7.7 South Africa Sales Analysis
  • 9.7.8 Rest Of Middle East And Africa Sales Analysis

10. COMPETITIVE LANDSCAPE OF THE EQUINE HEALTHCARE COMPANIES

• 10.1. Equine Healthcare Market Competition
• 10.2. Partnership/Collaboration/Agreement
• 10.3. Merger And Acquisitions
• 10.4. New Product Launch
• 10.5. Other Developments

11. COMPANY PROFILES OF EQUINE HEALTHCARE INDUSTRY

• 11.1. Top Companies Market Share Analysis
• 11.2. Market Concentration Rate
• 11.3. Zoetis
  • 11.3.1 Company Overview
  • 11.3.2 Company Revenue
  • 11.3.3 Products
  • 11.3.4 Recent Developments
• 11.4. Boehringer Ingelheim International GmbH
  • 11.4.1 Company Overview
  • 11.4.2 Company Revenue
  • 11.4.3 Products
  • 11.4.4 Recent Developments
• 11.5. Ceva
  • 11.5.1 Company Overview
  • 11.5.2 Company Revenue
  • 11.5.3 Products
  • 11.5.4 Recent Developments
• 11.6. Sound
  • 11.6.1 Company Overview
  • 11.6.2 Company Revenue
  • 11.6.3 Products
  • 11.6.4 Recent Developments
• 11.7. Merck & Co. Inc.
  • 11.7.1 Company Overview
  • 11.7.2 Company Revenue
  • 11.7.3 Products
  • 11.7.4 Recent Developments
• 11.8. Hallmarq Veterinary Imaging
  • 11.8.1 Company Overview
  • 11.8.2 Company Revenue
  • 11.8.3 Products
  • 11.8.4 Recent Developments
• 11.9. Esaote SPA
  • 11.9.1 Company Overview
  • 11.9.2 Company Revenue
  • 11.9.3 Products
  • 11.9.4 Recent Developments
• 11.10. Vetoquinol S.A.
  • 11.10.1 Company Overview
  • 11.10.2 Company Revenue
  • 11.10.3 Products
  • 11.10.4 Recent Developments
• 11.11. Idexx Laboratories Inc.
  • 11.11.1 Company Overview
  • 11.11.2 Company Revenue
  • 11.11.3 Products
  • 11.11.4 Recent Developments
• 11.12. Dechra Pharmaceuticals PLC
  • 11.12.1 Company Overview
  • 11.12.2 Company Revenue
  • 11.12.3 Products
  • 11.12.4 Recent Developments

Note - In company profiling, financial details and recent developments are subject to availability or might not be covered in the case of private companies